Morphofunctional evaluation of liver grafts obtained from standard donors and expanded criteria donors
https://doi.org/10.23873/2074-0506-2018-10-2-87-97
Abstract
Donor organ shortage stimulated an active use of donors with expanded evaluation criteria. The main evaluation method was a histological examination of liver graft biopsy specimens before (time-zero biopsy) and after reperfusion (time-1 biopsy). Severe ischemic and reperfusion injuries among recipients who received a liver graft made 20.4% and 16.6% respectively. The study showed no impact of small droplet, medium droplet, or even large droplet steatosis (less than 50%) on graft reperfusion injury.
About the Authors
M. Sh. KhubutiyaRussian Federation
Mogeli Sh. Khubutiya - Acad. of RAS, Professor, President of N.V. Sklifosovsky RIEM.
3 Bolshaya Sukharevskaya Square, Moscow 129090
L. N. Zimina
Russian Federation
3 Bolshaya Sukharevskaya Square, Moscow 129090
I. E. Galankina
Russian Federation
3 Bolshaya Sukharevskaya Square, Moscow 129090
V. A. Gulyaev
Russian Federation
3 Bolshaya Sukharevskaya Square, Moscow 129090
M. S. Novruzbekov
Russian Federation
3 Bolshaya Sukharevskaya Square, Moscow 129090
O. D. Olisov
Russian Federation
3 Bolshaya Sukharevskaya Square, Moscow 129090
K. M. Magomedov
Russian Federation
3 Bolshaya Sukharevskaya Square, Moscow 129090
References
1. Feng S., Goodrich N.P., Bragg-Gresham J.L., et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant. 2006;6(4):783–790. PMID:16539636 DOI:10.1111/j.1600-6143.2006.01242.x
2. Angelico M., Gridelli B., Strazzabosco M., A.I.S.F. Commission on Liver Transplantation. Practice of adult liver transplantation in Italy. Recommendations of the Italian Association for the Study of the Liver (A.I.S.F.). Dig Liver Dis. 2005;37(7):461–467. PMID:15893508 DOI:10.1016/j.dld.2005.03.006
3. Campbell M.S., Kotlyar D.S., Brensinger C.M., et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl. 2005;11(9):1048–1055. PMID:16123966 DOI:10.1002/lt.20445
4. Day C.P., James O.F. Hepatic steatosis: innocent bystander or guilty party? Hepatology. 1998;27(6):1463– 1466. PMID:9620314 DOI:10.1002/hep.510270601
5. Galankina I.E., Zimina L.N. Pathological aspects of organ allotransplantation. In: Khubutiya M.Sh.,ed. Transplantation of organs and tissues in a multidisciplinary research center. Moscow: Air Art Publ. 2011. Ch. 13: 347–378. (In Russian).
6. Gulyaev V.A. Increase in the efficiency of liver transplantation by improving the technology of seizure and preparation of a transplant: Dr. med. sci. diss. Moscow, 2016. 309 p. (In Russian).
7. Khubutiya M.Sh., Gulyaev V.A., Zimina L.N., et al. Comprehensive assessment of the liver after laparotomy in donor multiorgan. Russian Journal of Transplantology and Artificial Organs. 2012;(1):41–49. (In Russian).
8. Neil D.A., Hubsher S.G. Are parenchymal changes in early post-transplant biopsies related to preservationreperfusion injury or rejection? Biopsies related to preservation-reperfusion injury or rejection? Transplantation. 2001;71(11):1566–1572. PMID:11435966
9. Trevisani F., Colantoni A., Caraceni P., Van Thiel D.H. The use of donor fatty liver for liver transplantation: a challenge or a quagmire? J Hepatol. 1996;24(1):114–121. PMID:8834034
10. Ludwig J., Gross J.B. Jr, Perkins J.D., Moore S.B. Persistent centrilobular necrosis in hepatic allografts. Hum Pathol. 1990;21(6):656–661. PMID:2351393
11. Turlin B., Slapak G.I., Hayllar K.M., et al. Centrilobular necrosis after orthotopic liver transplantation: a longitudinal clinicopathologic study in 71 patients. Liver Transpl Surg. 1995;1(5):285–289. PMID:9346584
12. Fromenty B., Pessayre D. Impaired mitochondrial function in microvesicular steatosis: effects of drugs, ethanol, hormones and cytokines. J Hepatol. 1997;26(Suppl 2):43–53. PMID:9204409
13. Yoong K.F., Gunson B.K., Neil D.A., et al. Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc. 1999;31(1– 2):550–551. PMID:10083232.
14. Bao Y.M., Adam R., Sebagh M., et al. Risk factors of preservation injury and prognostic value of reperfusion biopsy in outcome of liver transplantation. Transplant Proc. 1996;28(1):123–125. PMID:8644141
15. Adam R., Reynes M., Johann M., et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc. 1991;23(1 Pt 2):1538–1540. PMID:1989281
16. Tillery W., Demetris J., Watkins D., et al. Pathological recognition of preservation injury in hepatic allografts with six months follow-up. Transplant Proc. 1989;21(1 Pt 2):1330–1331. PMID:2652439
Review
For citations:
Khubutiya M.Sh., Zimina L.N., Galankina I.E., Gulyaev V.A., Novruzbekov M.S., Olisov O.D., Magomedov K.M. Morphofunctional evaluation of liver grafts obtained from standard donors and expanded criteria donors. Transplantologiya. The Russian Journal of Transplantation. 2018;10(2):87-97. https://doi.org/10.23873/2074-0506-2018-10-2-87-97